Results 21 to 30 of about 81,119 (304)

Pre-exposure prophylaxis of HIV

Indian Journal of Sexually Transmitted Diseases and AIDS, 2011
Pre-exposure prophylaxis (PrEP) is an experimental approach to HIV prevention and consists of antiretroviral drugs to be taken before potential HIV exposure in order to reduce the risk of HIV infection and continued during periods of risk. An effective PrEP could provide an additional safety net to sexually active persons at risk, when combined with ...
Naswa, Smriti, Marfatia, Y. S.
openaire   +3 more sources

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. [PDF]

, 2010
There are currently several ongoing or planned trials evaluating the efficacy of pre-exposure prophylaxis (PrEP) as a preventative approach to reducing the transmission of HIV.
Warren, M, Kim, SC, Dieffenbach, Carl, Blair S Hanewall, Becker, Stephen, Lo, Ying-Ru, Catherine Hankins, Paxton, L, Ying‐Ru Lo, Mellors, John W., Lo, YR, O'Reilly, K, John W Mellors, Dybul, MR, Mitchell Warren, Dybul, Mark R, Ying-Ru Lo, Susan C Kim, Hanewall, Blair S, Mellors, JW, Lynn Paxton, Roffenbender, JS, Paxton, Lynn, Kim, Susan C, Mellors, John W, Roffenbender, Jason S, Dieffenbach, C, Piot, P, Kevin O'Reilly, Peter Piot, Carl Dieffenbach, O'Reilly, Kevin, Stephen Becker, Hankins, Catherine, Piot, Peter, Warren, Mitchell, Hankins, C, Mark R Dybul, Becker, S, Hanewall, BS, Jason S Roffenbender   +40 more
core   +1 more source

Pre-Exposure prophylaxis studies (N = 19).

, 2022
Pre-Exposure prophylaxis studies (N = 19).
Mathias Lalika (12359774), Rena C. Patel (3387779), David M. Koelle (8138436), Aldina Mesic (12359768), Emahlea K. Jackson (12359771)   +4 more
core   +1 more source

Online Navigation for Pre-Exposure Prophylaxis via PleasePrEPMe Chat for HIV Prevention: Protocol for a Development and Use Study

JMIR Research Protocols, 2020
BackgroundPre-exposure prophylaxis is an HIV medication taken by an individual who is HIV-negative to prevent infection before exposure to the virus.
Weber, Shannon, Lazar, Laura, McCord, Alan, Romero, Charlie, Tan, Judy   +4 more
doaj   +1 more source

Trends in Recommended Screening and Monitoring Tests for Users of HIV Pre-Exposure Prophylaxis Before and During the COVID-19 Pandemic

AJPM Focus, 2023
Introduction: To ensure the health and safety of persons taking pre-exposure prophylaxis to prevent HIV infection, the 2017 Centers for Disease Control and Prevention guidelines recommended initial and follow-up laboratory testing. We assessed the trends
Ikenna F. Unigwe, PharmD, Robert L. Cook, MD, Jennifer W. Janelle, MD, Haesuk Park, PhD   +3 more
doaj   +1 more source

Rectal pre-exposure prophylaxis (PrEP) [PDF]

Antiviral Research, 2013
Rectal pre-exposure prophylaxis (PrEP) will be a critical component of HIV prevention products due to the prevalence of unprotected receptive anal intercourse among men who have sex with men and heterosexual couples. Given the biological considerations of this compartment and the complexity of HIV infection, design of a successful rectal microbicide ...
Lisa C, Rohan, Haitao, Yang, Lin, Wang
openaire   +2 more sources

Pre-exposure prophylaxis and primary care

British Journal of General Practice, 2020
Despite the increasing evidence of the effectiveness of pre-exposure prophylaxis (PrEP) as a HIV prevention strategy, its usefulness is rarely reported in the general practice literature.1 HIV infection remains a major public health concern worldwide and it is men who have sex with men (MSM) that carry a disproportionate amount of the disease burden.2
Des, Crowley, Walter, Cullen, Patrick, O'Donnell   +2 more
openaire   +3 more sources

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. [PDF]

, 2012
BACKGROUND: The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposure prophylaxis (PrEP) has shown promising results in recent trials.
Garnett, Geoffrey P, Piot, PK, Ana Wheelock, Wheelock, A, Gomez Gabriela B., Wheelock, Ana, Gomez, Gabriela B, Geoffrey P Garnett, Eisingerich, Andreas B., Garnett Geoffrey P., Peter K Piot, Dybul Mark R., Mark R. Dybul, Dybul, MR, Gomez, Gabriela B., Dybul, Mark R., Dybul, Mark R, Peter K. Piot, Geoffrey P. Garnett, Gomez, GB, Piot, Peter K, Piot, Peter K., Gabriela B Gomez, Wheelock Ana, Andreas B Eisingerich, Garnett, Geoffrey P., Piot Peter K., Gabriela B. Gomez, Eisingerich, Andreas B, Eisingerich, AB, Garnett, GP, Mark R Dybul, Andreas B. Eisingerich, Eisingerich Andreas B.   +33 more
core   +1 more source

US Black cisgender women and pre-exposure prophylaxis for human immunodeficiency virus prevention: A scoping review

Women's Health, 2022
Background: Black cisgender women in the United States experience a disproportionate burden of human immunodeficiency virus acquisition. Pre-exposure prophylaxis is an effective oral daily medication that reduces the risk of human immunodeficiency virus ...
Cherie Conley, Ragan Johnson, Keosha Bond, Sullivan Brem, Jasmine Salas, Schenita Randolph   +5 more
doaj   +1 more source

A community perspective on pre‐exposure prophylaxis [PDF]

Journal of the International AIDS Society, 2014
The history of pre‐exposure prophylaxis (PrEP) is notable for being a community rather than industry‐driven development. This talk will review this history, covering factors that include community demand, study results, regulatory challenges, commercial interests and practical issues of public health. It will also look at some of the controversies that
openaire   +2 more sources